Examkin

Question

Difficulty: Very hardPharmacological and Parenteral Therapies

During the management of a critically ill adult in the intensive care unit, a triple-lumen central venous catheter (CVC) is utilized for multiple continuous infusions. The client's distal lumen is infusing epinephrine to maintain hemodynamic stability, the medial lumen is reserved for continuous total parenteral nutrition (TPN), and the proximal lumen is delivering a standard heparin protocol. Suddenly, the cardiac monitor displays symptomatic supraventricular tachycardia (SVT), and the healthcare provider prescribes an immediate dose of adenosine via rapid intravenous push. Which parenteral administration technique represents the safest clinical judgment?

  1. Pause the heparin infusion, aspirate blood from the proximal lumen to clear residual medication, flush with 0.9% sodium chloride, rapidly administer the adenosine followed by a 20 mL flush, and restart the heparin.Answer
  2. B
    Pause the epinephrine infusion, administer the adenosine rapidly through the distal lumen's most proximal injection port, follow immediately with a 20 mL flush, and restart the epinephrine.
  3. C
    Administer the adenosine rapidly through the Y-site of the medial lumen without pausing the TPN, utilizing the continuous flow to assist in pushing the medication centrally.
  4. D
    Withhold the adenosine until another clinician can establish a large-bore peripheral intravenous catheter in the antecubital fossa to prevent disrupting the critical central infusions.

Answer

The safest method is to pause the heparin infusion, aspirate the residual drug from the proximal lumen, flush with saline, administer the adenosine, flush again, and restart the heparin.
The option describing pausing the heparin, aspirating the line, and flushing before and after administration is correct because it identifies the only safe lumen to use. Aspiration is critical; it removes the residual heparin in the catheter's dead space, preventing an accidental bolus. A brief pause in heparin therapy will not harm the client, and this route provides the necessary central access for a drug with an ultra-short half-life like adenosine.

Step-by-Step Solution

1
Analyze the pharmacological properties of the prescribed emergency medication.
Adenosine has an ultra-short half-life (under 10 seconds) and requires rapid IV push followed immediately by a rapid flush. Central venous access is highly advantageous for delivery directly to the heart.
Understanding the pharmacokinetic requirements dictates the need for the fastest and most direct intravenous route available.
2
Evaluate the safety of utilizing the distal lumen infusing epinephrine.
The catheter tubing (dead space) is filled with concentrated epinephrine. Flushing this line to push adenosine would simultaneously deliver a massive bolus of epinephrine into the central circulation.
Administering a bolus of a potent chronotropic/vasopressor agent to a client in symptomatic SVT could trigger a lethal hypertensive crisis or myocardial infarction. This lumen is contraindicated for flushing.
3
Evaluate the safety of utilizing the medial lumen infusing TPN.
Standard parenteral therapy protocols strictly prohibit administering IV push medications through a TPN line due to extreme incompatibility risks, lipid emulsion destabilization, and high infection rates.
Maintaining the integrity of a dedicated TPN line is a core patient safety standard.
4
Determine the optimal management of the proximal lumen infusing heparin.
Heparin has a comparatively longer half-life and does not cause immediate hemodynamic collapse if paused for one minute. By pausing the infusion and aspirating the blood/drug from the dead space, the nurse safely clears the lumen.
Aspiration prevents an unintended heparin bolus. This provides a safe, clear central pathway for the emergency administration of adenosine without delaying care to start a peripheral line.

Key Concept

Central Venous Catheter Dead Space and High-Alert Medication Compatibility
Rate this question

Topics

Pharmacological and Parenteral Therapies

More questions from this topic